Is Vertex Stock Still a Good Buy?
Over the past ten years or so, Vertex Pharmaceuticals (NASDAQ:…
Sell
25
SLAB Quote, Financials, Valuation and Earnings
Last price:
$101.77
Seasonality move
:
-0.6%
Day range:
$99.40 - $103.61
52-week range:
$82.82 - $160.00
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
5.60x
P/B ratio:
3.06x
Volume:
266.6K
Avg. volume:
476.7K
1-year change:
-17.8%
Market cap:
$3.3B
Revenue:
$584.4M
EPS (TTM):
-$5.94
Analysts' Opinion
-
Consensus RatingSilicon Laboratories has received a consensus rating of Hold. The company's average rating is a Hold based on 3 Buy ratings, 6 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $134.33, Silicon Laboratories has an estimated upside of 32.06% from its current price of $101.72.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $80.00 representing 100% downside risk from its current price of $101.72.
Fair Value
-
According to the consensus of 9 analysts, Silicon Laboratories has 32.06% upside to fair value with a price target of $134.33 per share.
SLAB vs. S&P 500
-
Over the past 5 trading days, Silicon Laboratories has overperformed the S&P 500 by 6.37% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Silicon Laboratories does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Silicon Laboratories has grown year-over-year revenues for 1 quarter straight. In the most recent quarter Silicon Laboratories reported revenues of $166.2M.
Earnings Growth
-
Silicon Laboratories earnings have been falling on a year-over-year basis for 3 quarters in a row. In the most recent quarter Silicon Laboratories reported earnings per share of -$0.73.
Enterprise value:
2.9B
EV / Invested capital:
--
Price / LTM sales:
5.60x
EV / EBIT:
--
EV / Revenue:
5.00x
PEG ratio (5yr expected):
-0.04x
EV / Free cash flow:
-113.78x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
$312.2M
Return On Assets:
-14.67%
Net Income Margin (TTM):
-32.69%
Return On Equity:
-16.97%
Return On Invested Capital:
-16.83%
Operating Margin:
-17.22%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Income Statement | ||||||
| Revenue | $1B | $782.3M | $584.4M | $86.8M | $166.2M | |
| Gross Profit | $642.6M | $460.6M | $312.2M | $43.9M | $90.2M | |
| Operating Income | $119.3M | -$24.2M | -$165.5M | -$73.1M | -$28.6M | |
| EBITDA | $189.8M | $46.1M | -$104.9M | -$56.6M | -$14M | |
| Diluted EPS | $2.54 | -$1.13 | -$5.94 | -$2.19 | -$0.73 | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $975.8M | $2.2B | $1.5B | $737.9M | $602M | |
| Total Assets | $2B | $3B | $2.2B | $1.4B | $1.2B | |
| Current Liabilities | $284.5M | $668.8M | $185.8M | $163.6M | $97.9M | |
| Total Liabilities | $793.6M | $745.9M | $764.4M | $234.4M | $142.7M | |
| Total Equity | $1.2B | $2.2B | $1.4B | $1.2B | $1.1B | |
| Total Debt | $563.4M | $450.6M | $529.6M | $45M | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $71.8M | -$30.3M | -$13.9M | $18.5M | $10.1M | |
| Cash From Investing | $240.5M | $469.8M | $113.1M | $43.4M | -$38.2M | |
| Cash From Financing | -$887.1M | -$711.9M | -$45.1M | $5.6M | $6.6M | |
| Free Cash Flow | $45.3M | -$52.6M | -$25.7M | $14.8M | $6.2M | |
SLAB
Sector
Market Cap
$3.3B
$78.3M
Price % of 52-Week High
63.58%
57.88%
Dividend Yield
0%
0%
Shareholder Yield
-0.18%
0.76%
1-Year Price Total Return
-17.8%
-18.18%
Beta (5-Year)
1.326
0.870
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$97.80
200-day SMA
Sell
Level
$117.82
Bollinger Bands (100)
Sell
Level
107.07 - 142.07
Chaikin Money Flow
Buy
Level
6.8M
20-day SMA
Buy
Level
$96.61
Relative Strength Index (RSI14)
Sell
Level
47.49
ADX Line
Sell
Level
25.3
Williams %R
Sell
Level
-13.3127
50-day SMA
Sell
Level
$118.59
MACD (12, 26)
Sell
Level
-4.62
25-day Aroon Oscillator
Sell
Level
-44
On Balance Volume
Neutral
Level
18.3M
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (18.6638)
Buy
CA Score
(Annual)
Level (0.8337)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (6)
Buy
Ohlson Score
Level (-1.0295)
Buy
Piotroski F Score
(Annual)
Level (5)
Sell
Quality Ratio Score
Level (4)
Buy
Fundamental Score
Level (6)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Silicon Laboratories Inc Inc is a provider of secure, intelligent wireless technology for a more connected world. The company's integrated hardware and software platform, intuitive development tools, industry ecosystem, and robust support help customers build industrial, commercial, home, and life applications. Company make it easy for developers to solve complex wireless challenges throughout the product lifecycle and get to market quickly with solutions that transform industries, grow economies, and improve lives. Company operates in USA, China, Taiwan and Rest of World, with maximum revenue from rest of the world.
Stock Forecast FAQ
In the current month, SLAB has received 3 Buy ratings 6 Hold ratings, and 0 Sell ratings. The SLAB average analyst price target in the past 3 months is $134.33.
-
Where Will Silicon Laboratories Stock Be In 1 Year?
According to analysts, the consensus estimate is that Silicon Laboratories share price will rise to $134.33 per share over the next 12 months.
-
What Do Analysts Say About Silicon Laboratories?
Analysts are divided on their view about Silicon Laboratories share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Silicon Laboratories is a Sell and believe this share price will drop from its current level to $80.00.
-
What Is Silicon Laboratories's Price Target?
The price target for Silicon Laboratories over the next 1-year time period is forecast to be $134.33 according to 9 Wall Street analysts, 3 of them rate the stock a Buy, 0 rate the stock a Sell, and 6 analysts rate the stock a Hold.
-
Is SLAB A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Silicon Laboratories is a Hold. 6 of 9 analysts rate the stock a Hold at this time.
-
How Can I Buy Shares Of SLAB?
You can purchase shares of Silicon Laboratories via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Silicon Laboratories shares.
-
What Is The Silicon Laboratories Share Price Today?
Silicon Laboratories was last trading at $101.77 per share. This represents the most recent stock quote for Silicon Laboratories. Yesterday, Silicon Laboratories closed at $101.72 per share.
-
How To Buy Silicon Laboratories Stock Online?
In order to purchase Silicon Laboratories stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Related Companies
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Okta Stock Finally Gaining Investor Confidence?
Given how digital transformation has proliferated, cyberattacks have also been…
Is The Trade Desk the Best Advertising Stock Now?
The worldly backdrop is now shrouded in heavy uncertainty and…
Stock Ideas
Buy
59
Is AAPL Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 35x
Buy
58
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Buy
55
Is NVDA Stock a Buy?
Market Cap: $2.7T
P/E Ratio: 37x
Alerts
Buy
85
HIMS alert for Apr 30
Hims & Hers Health [HIMS] is down 5.48% over the past day.
Buy
54
EAT alert for Apr 30
Brinker International [EAT] is down 1.82% over the past day.
Sell
16
NSP alert for Apr 30
Insperity [NSP] is down 3.3% over the past day.
